Erratum for the Research Article: "The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study" by P. Kiessling, R. Lledo-Garcia, S. Watanabe, G. Langdon, D. Tran, M. Bari, L. Christodoulou, E. Jones, G. Price, B. Smith, F. Brennan, I. White, S. Jolles

Sci Transl Med. 2017 Dec 6;9(419):eaar6448. doi: 10.1126/scitranslmed.aar6448.
No abstract available

Publication types

  • Published Erratum